References
1. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2
infection and potential evidence for persistent fecal viral shedding.Nat Med . 2020. doi:10.1038/s41591-020-0817-4
2. Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies
and immunodeficiencies during respiratory virus epidemics – the 2020
COVID‐19 pandemic. Pediatr Allergy Immunol . 2020:0-3.
doi:10.1111/pai.13262
3. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N
Engl J Med . 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073
4. Henderson LA, Cron RQ. Macrophage Activation Syndrome and Secondary
Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders:
Diagnosis and Management. Pediatr Drugs . 2020;22(1):29-44.
doi:10.1007/s40272-019-00367-1
5. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of
mortality due to COVID ‑ 19 based on an analysis of data of 150 patients
from Wuhan , China. Intensive Care Med . 2020.
doi:10.1007/s00134-020-05991-x
6. Nelson DL, Rubin LA, Kurman CC, Fritz ME, Boutin B. An analysis of
the cellular requirements for the production of soluble interleukin-2
receptors in vitro. J Clin Immunol . 1986;6(2):114-120.
doi:10.1007/BF00918743
7. Zhang B, Zhou X, Zhu C, et al. Immune phenotyping based on
neutrophil-to-lymphocyte ratio and IgG predicts disease severity and
outcome for patients with COVID-19. medRxiv .
2020:2020.03.12.20035048. doi:10.1101/2020.03.12.20035048
8. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in
Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin
Infect Dis . 2020;2019(Xx Xxxx):4-10. doi:10.1093/cid/ciaa248
9. Wilk AJ, Rustagi A, Zhao NQ, et al. A single-cell atlas of the
peripheral immune response to severe COVID-19. medRxiv . 2020.
doi:https://doi.org/10.1101/2020.04.17.20069930
10. Marini O, Costa S, Bevilacqua D, et al. Mature CD10+ and immature
CD10− neutrophils present in G-CSF–treated donors display opposite
effects on T cells. Blood . 2017;129(10):1343-1356.
doi:10.1182/blood-2016-04-713206